ZELBORAF (vemurafenib) tablet

ZELBORAF is a brand-name prescription drug that’s FDA-approved to treat melanoma. Brand Name: ZELBORAF (vemurafenib) tablet for oral use Initial U.S. Approval: 2011

Home | vemurafenib tablet

ZELBORAF (vemurafenib) tablet price in India and Overseas
ZELBORAF (vemurafenib) tablet

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

ZELBORAF (vemurafenib) tablet

Vemurafenib is approved to treat patients whose cancer has a certain mutation in the BRAF gene, including: Erdheim-Chester disease, Melanoma. Vemurafenib is also being studied in the treatment of other types of cancer.

Zelboraf, A drug used to treat Erdheim-Chester disease (a very rare type of histiocytosis) and advanced melanoma that have a certain mutation (change) in the BRAF gene. It is also being studied in the treatment of other types of cancer. Zelboraf blocks certain proteins made by the mutated BRAF gene, which may help keep cancer cells from growing. It is a type of kinase inhibitor. Also called BRAF (V600E) kinase inhibitor RO5185426, PLX4032, RG7204, and vemurafenib.

Vemurafenib, A drug used to treat Erdheim-Chester disease (a very rare type of histiocytosis) and advanced melanoma that have a certain mutation (change) in the BRAF gene. It is also being studied in the treatment of other types of cancer. Vemurafenib blocks certain proteins made by the mutated BRAF gene, which may help keep cancer cells from growing. It is a type of kinase inhibitor. Also called BRAF (V600E) kinase inhibitor RO5185426, PLX4032, RG7204, and Zelboraf.

Drug (Brand / Generic): ZELBORAF / vemurafenib
Current Indications: Erdheim-Chester disease
Marketed by:: Genentech
Approval Date: 2011

Available as (Form & Strength): Tablet: 240 mg

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.